Literature DB >> 8670825

Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47.

K Ahn1, T H Meyer, S Uebel, P Sempé, H Djaballah, Y Yang, P A Peterson, K Früh, R Tampé.   

Abstract

The immediate early protein ICP47 of herpes simplex virus (HSV) inhibits the transporter for antigen processing (TAP)-mediated translocation of antigen-derived peptides across the endoplasmic reticulum (ER) membrane. This interference prevents assembly of peptides with class I MHC molecules in the ER and ultimately recognition of HSV-infected cells by cytotoxic T-lymphocytes, potentially leading to immune evasion of the virus. Here, we demonstrate that recombinant, purified ICP47 containing a hexahistidine tag inhibits peptide import into microsomes of insect cells expressing human TAP, whereas inhibition of peptide transport by murine TAP was much less effective. This finding indicates an intrinsic species-specificity of ICP47 and suggests that no additional proteins interacting specifically with either ICP47 or TAP are required for inhibition of peptide transport. Since neither purified nor induced ICP47 inhibited photocrosslinking of 8-azido-ATP to TAP1 and TAP2 it seems that ICP47 does not prevent ATP from binding to TAP. By contrast, peptide binding was completely blocked by ICP47 as shown both by photoaffinity crosslinking of peptides to TAP and peptide binding to microsomes from TAP-transfected insect cells. Competition experiments indicated that ICP47 binds to human TAP with a higher affinity (50 nM) than peptides whereas the affinity to murine TAP was 100-fold lower. Our data suggest that ICP47 prevents peptides from being translocated by blocking their binding to the substrate-binding site of TAP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670825      PMCID: PMC451885     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

1.  An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens.

Authors:  H G Burgert; S Kvist
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

2.  A viral inhibitor of peptide transporters for antigen presentation.

Authors:  K Früh; K Ahn; H Djaballah; P Sempé; P M van Endert; R Tampé; P A Peterson; Y Yang
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

3.  Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigen.

Authors:  A Hill; H Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

4.  Characteristics of peptide and major histocompatibility complex class I/beta 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2).

Authors:  M J Androlewicz; B Ortmann; P M van Endert; T Spies; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

5.  A sequential model for peptide binding and transport by the transporters associated with antigen processing.

Authors:  P M van Endert; R Tampé; T H Meyer; R Tisch; J F Bach; H O McDevitt
Journal:  Immunity       Date:  1994-09       Impact factor: 31.745

6.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.

Authors:  K L Rock; C Gramm; L Rothstein; K Clark; R Stein; L Dick; D Hwang; A L Goldberg
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

7.  Interaction of MHC class I molecules with the transporter associated with antigen processing.

Authors:  W K Suh; M F Cohen-Doyle; K Fruh; K Wang; P A Peterson; D B Williams
Journal:  Science       Date:  1994-05-27       Impact factor: 47.728

8.  Herpes simplex virus turns off the TAP to evade host immunity.

Authors:  A Hill; P Jugovic; I York; G Russ; J Bennink; J Yewdell; H Ploegh; D Johnson
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

9.  Nucleotide binding of the C-terminal domains of the major histocompatibility complex-encoded transporter expressed in Drosophila melanogaster cells.

Authors:  K Wang; K Früh; P A Peterson; Y Yang
Journal:  FEBS Lett       Date:  1994-08-22       Impact factor: 4.124

10.  Human transporters associated with antigen processing possess a promiscuous peptide-binding site.

Authors:  M J Androlewicz; P Cresswell
Journal:  Immunity       Date:  1994-04       Impact factor: 31.745

View more
  113 in total

1.  Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.

Authors:  T Todo; R L Martuza; S D Rabkin; P A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

2.  Allosteric crosstalk between peptide-binding, transport, and ATP hydrolysis of the ABC transporter TAP.

Authors:  S Gorbulev; R Abele; R Tampé
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease.

Authors:  Christopher S Morello; Michael S Levinson; Kimberly A Kraynyak; Deborah H Spector
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 4.  The MHC class I antigen presentation pathway: strategies for viral immune evasion.

Authors:  Eric W Hewitt
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

5.  Epstein-Barr viral BNLF2a protein hijacks the tail-anchored protein insertion machinery to block antigen processing by the transport complex TAP.

Authors:  Agnes I Wycisk; Jiacheng Lin; Sandra Loch; Kathleen Hobohm; Jessica Funke; Ralph Wieneke; Joachim Koch; William R Skach; Peter U Mayerhofer; Robert Tampé
Journal:  J Biol Chem       Date:  2011-10-07       Impact factor: 5.157

Review 6.  ABC proteins in antigen translocation and viral inhibition.

Authors:  David Parcej; Robert Tampé
Journal:  Nat Chem Biol       Date:  2010-08       Impact factor: 15.040

7.  Herpes Simplex Virus 1 US3 Phosphorylates Cellular KIF3A To Downregulate CD1d Expression.

Authors:  Ran Xiong; Ping Rao; Seil Kim; Michelle Li; Xiangshu Wen; Weiming Yuan
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

8.  Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing.

Authors:  Danijela Koppers-Lalic; Eric A J Reits; Maaike E Ressing; Andrea D Lipinska; Rupert Abele; Joachim Koch; Marisa Marcondes Rezende; Pieter Admiraal; Daphne van Leeuwen; Krystyna Bienkowska-Szewczyk; Thomas C Mettenleiter; Frans A M Rijsewijk; Robert Tampé; Jacques Neefjes; Emmanuel J H J Wiertz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-25       Impact factor: 11.205

9.  Psychological stress compromises CD8+ T cell control of latent herpes simplex virus type 1 infections.

Authors:  Michael L Freeman; Brian S Sheridan; Robert H Bonneau; Robert L Hendricks
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

Review 10.  The challenge of developing a herpes simplex virus 2 vaccine.

Authors:  Lesia K Dropulic; Jeffrey I Cohen
Journal:  Expert Rev Vaccines       Date:  2012-12       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.